- Previous Close
15.02 - Open
14.91 - Bid 13.00 x 800
- Ask --
- Day's Range
14.06 - 15.02 - 52 Week Range
6.62 - 17.67 - Volume
670,805 - Avg. Volume
636,333 - Market Cap (intraday)
1.215B - Beta (5Y Monthly) 1.49
- PE Ratio (TTM)
-- - EPS (TTM)
-1.19 - Earnings Date May 5, 2025 - May 9, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
18.36
Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal medicine nurse practitioners, certified nurse mid-wives, sonographers, and genetic counselors. In addition, it offers other pediatric subspecialty care services, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and other newborn and pediatric care, as well as newborn hearing screening, and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
www.pediatrix.com4,120
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: MD
View MorePerformance Overview: MD
Trailing total returns as of 3/28/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: MD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: MD
View MoreValuation Measures
Market Cap
1.22B
Enterprise Value
1.53B
Trailing P/E
--
Forward P/E
9.10
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.59
Price/Book (mrq)
1.59
Enterprise Value/Revenue
0.76
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.92%
Return on Assets (ttm)
5.25%
Return on Equity (ttm)
-12.28%
Revenue (ttm)
2.01B
Net Income Avi to Common (ttm)
-99.07M
Diluted EPS (ttm)
-1.19
Balance Sheet and Cash Flow
Total Cash (mrq)
348.51M
Total Debt/Equity (mrq)
86.58%
Levered Free Cash Flow (ttm)
173.92M